AAPL
52
4
ADI
54
3
AMP
66
3
NEM
50
2
HRL
44
3
NUE
47
3
COF
49
2
CLX
68
2
MNST
61
2
TRV
59
7
CMS
68
3
PPL
80
5
KIM
54
3
CCL
53
6
RSG
73
3
ZBH
65
3
TEL
63
5
QCOM
56
5
AMAT
36
6
R
61
4
AAPL
52
4
ADI
54
3
AMP
66
3
NEM
50
2
HRL
44
3
NUE
47
3
COF
49
2
CLX
68
2
MNST
61
2
TRV
59
7
CMS
68
3
PPL
80
5
KIM
54
3
CCL
53
6
RSG
73
3
ZBH
65
3
TEL
63
5
QCOM
56
5
AMAT
36
6
R
61
4
Financhill
Back

Intelligent Bio Solutions 10K Form

Sell
47

INBS
Intelligent Bio Solutions

Last Price:
$2.13
Seasonality Move:
-27.59%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INBS News And Ratings

See the #1 stock for the next 7 days that we like better than INBS

INBS Financial Statistics

Sales & Book Value

Annual Sales: $3.1M
Cash Flow: $-2.3M
Price / Cash Flow: 0
Annual Sales: $0.91
Price / Book: 2.6

Profitability

EPS (TTM): -3.43570
Net Income (TTM): $-10.7M
Gross Margin: $1.4M
Return on Equity: -164.63%
Return on Assets: -89.06%

Intelligent Bio Solutions Earnings Forecast

Key Intelligent Bio Solutions Financial Ratios

  • The Gross Profit Margin over the past 3 years for INBS is 45.81%.
  • The Selling, General & Administrative Expenses for INBS have been equal to 297.53% of Gross Profit Margin.
  • The Research & Development expenses have been 53.79% of Revenue.
  • The Net Earning history of INBS is -326.40% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 4 years.

Intelligent Bio Solutions Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: INBS
Website: gbs.inc

Debt

Debt-to-Equity Ratio: 0.09
Current Ratio: 0.92
Quick Ratio: 0.66

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INBS Technical Analysis vs Fundamental Analysis

Sell
47
Intelligent Bio Solutions (INBS) is a Sell

Is Intelligent Bio Solutions a Buy or a Sell?